PIONEERING ANTI-TUMOR IMMUNE REDIRECTION

OUR MISSION


VerImmune seeks to transform the lives of cancer patients through the development of highly effective immuno-medicines, while ensuring low toxicity and durable benefit across a broad range of cancers.

 
infograhpic.png

IMMUNE MEMORY DEVELOPMENT

Long-lasting immune memory stems from childhood vaccines or past viral infections.

infographic2.png

CANCER DIAGNOSIS

Pre-existing immune memory is retained to adulthood when diagnosed with cancer.

infographic3.png

ANTI-TUMOR IMMUNE REDIRECTION (AIR)

AIR therapy leverages
and redirects pre-existing immune memory
towards cancer.

infographic4.png

CANCER DESTRUCTION

Redirected pre-existing immunity leads to tumor cell death.


About Us


Founded in Baltimore Maryland, and now located at JLAB@Washington DC,
VerImmune is biotechnology company developing a novel first-in-class cancer therapy known as Anti-tumor Immune Redirection (AIR). This strategy utilizes a proprietary virus-inspired particle (ViP) technology platform that redirects pre-existing pathogenic or childhood vaccine immune memory towards tumors.

 

Zoom_DC+skyline.jpg

 


Our Team


 

Board of Directors



Investors & Partners



Scientific Advisory & Collaborators